{"id":50431,"date":"2024-11-04T15:04:22","date_gmt":"2024-11-04T07:04:22","guid":{"rendered":"https:\/\/biopioneer.com.tw\/?p=50431"},"modified":"2025-11-15T16:39:22","modified_gmt":"2025-11-15T08:39:22","slug":"streptozocin-cas18883-66-4-apexbio-%e8%b2%a8%e8%99%9fa4457","status":"publish","type":"post","link":"https:\/\/biopioneer.com.tw\/?p=50431","title":{"rendered":"Streptozocin | CAS#18883-66-4 APExBIO\u00a0 \u8ca8\u865fA4457"},"content":{"rendered":"<p><strong><span style=\"font-size: 12pt; color: #ff6600;\"><span style=\"font-size: 14pt;\"><span style=\"color: #800080;\">\u6297\u751f\u7d20\u548c\u6297\u816b\u7624\u5291\u7cfb\u5217\u5546\u54c1-&gt;&gt;<span style=\"color: #ff6600;\">Streptozocin<\/span><\/span><\/span><\/span><\/strong><\/p>\n<p>APExBIO Technology LLC \u662f\u4e00\u5bb6\u9818\u5148\u7684\u5c0f\u5206\u5b50\u6291\u5236\u5291(Small Molecule Inhibitors)\/\u6d3b\u5316\u5291(Activators)\u3001\u5316\u5408\u7269\u5eab( Compound Libraries)\u3001\u80dc\u80bd(Peptides)\u3001\u6aa2\u6e2c\u8a66\u5291\u76d2(Assay Kits)\u3001\u87a2\u5149\u6a19\u8a18(Fluorescent Label)\u3001\u9176(Enzymes)\u3001\u4fee\u98fe\u6838\u82f7\u9178(Modified Nucleotides)\u3001mRNA \u5408\u6210\u4ee5\u53ca\u5404\u7a2e\u5206\u5b50\u751f\u7269\u5b78\u5de5\u5177\u7684\u4f9b\u61c9\u5546\u3002APExBIO\u63d0\u4f9b\u5ee3\u6cdb\u7684\u7522\u54c1\u7dda\uff0c\u6db5\u84cb 20 \u591a\u500b\u4e0d\u540c\u7684\u7814\u7a76\u9818\u57df\uff0c\u4f8b\u5982\u764c\u75c7(cancer)\u3001\u514d\u75ab\u5b78(immunology)\u3001\u795e\u7d93\u79d1\u5b78(neurosciences)\u3001\u7d30\u80de\u51cb\u4ea1(apoptosis)\u548c\u8868\u89c0\u907a\u50b3\u5b78(epigenetics)\u7b49\u3002\u516c\u53f8\u7e3d\u90e8\u4f4d\u65bc\u7f8e\u570b\u5fb7\u5dde\u4f11\u58eb\u9813USA (Houston, Texas)\uff0c\u81f4\u529b\u65bc\u670d\u52d9\u5168\u7403\u5ba2\u6236\u3002\u9ad8\u5ea6\u91cd\u8996\u7522\u54c1\u54c1\u8cea\u3002\u6240\u6709\u7522\u54c1\u5747\u9075\u5faa\u56b4\u683c\u7684\u751f\u7522\u6307\u5357\uff0c\u4e26\u9644\u6709\u5206\u6790\u8b49\u66f8\u3001HPLC\u3001\u8cea\u8b5c(Mass Spectrum)\u548cHMNR\u4ee5\u53ca\u9ad4\u5916\u9a57\u8b49(in vitro validation)\u3002 APExBIO\u7522\u54c1\u5df2\u88ab\u300aNature\u300b\u3001\u300aCell\u300b\u548c\u300aScience\u300b\u7b49\u773e\u591a\u9802\u7d1a\u540c\u884c\u8a55\u5be9\u671f\u520a\u5f15\u7528\u3002<a href=\"https:\/\/biopioneer.com.tw\/?news=apexbio%e5%8f%b0%e7%81%a3%e4%bb%a3%e7%90%86%e5%95%86-brandagency%e4%bb%a3%e7%90%86%e5%93%81%e7%89%8c-apexbio-2\"><span style=\"color: #ff0000;\"><em><strong><span style=\"text-decoration: underline;\">&gt;&gt;\u66f4\u591aAPExBio\u5546\u54c1<\/span><\/strong><\/em><\/span><\/a><\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"https:\/\/biopioneer.com.tw\/wp-content\/uploads\/downloads\/2025\/06\/%E5%A4%AA%E9%BC%8E-APExBIO-Technology-LLC-%E5%93%81%E7%89%8C.png\" width=\"1099\" height=\"274\" \/><\/p>\n<p><span style=\"color: #00ccff; font-size: 12pt;\"><a style=\"color: #00ccff;\" href=\"https:\/\/biopioneer.com.tw\/?p=50431&amp;preview=true\">Streptozocin| CAS#18883-66-4 APExBIO\u00a0 \u8ca8\u865fA4457<\/a><\/span><\/p>\n<p>Antibiotic and antitumor agent<\/p>\n<p>Antibiotic and antitumor agent. Alkylates DNA and induces diabetes mellitus via reduction of nicotinamide adenine dinucleotide in pancreatic \u03b2-cells\u00a0<em>in vivo<\/em>.Streptozotocin (65 mg\/kg) resulted in rapid degranulation of \u03b2 cells, accumulation of glycogen in the proximal convoluted tubules of the kidney, as well as development of cataracts in 4 months after streptozotocin treatment. At a higher dose of 100 mg\/kg, streptozotocin produced lesions in the exocrine cells of the pancreas, and led to persistence of small, possibly secretory, granules in the Golgi zone of \u03b2 cells in diabetic rats. Streptozotocin is often used to induce diabetes mellitus in experimental animals.<\/p>\n<p>\u93c8\u8132\u4f50\u83cc\u7d20\uff0865 mg\/kg\uff09\u5c0e\u81f4\u03b2\u7d30\u80de\u5feb\u901f\u812b\u9846\u7c92\uff0c\u814e\u81df\u8fd1\u66f2\u5c0f\u7ba1\u809d\u91a3\u7a4d\u805a\uff0c\u4e26\u5728\u93c8\u8132\u4f50\u83cc\u7d20\u6cbb\u7642\u5f8c4\u500b\u6708\u5167\u51fa\u73fe\u767d\u5167\u969c\u3002\u5728 100 mg\/kg \u7684\u8f03\u9ad8\u5291\u91cf\u4e0b\uff0c\u93c8\u8132\u4f50\u83cc\u7d20\u6703\u5728\u80f0\u81df\u5916\u5206\u6ccc\u7d30\u80de\u7522\u751f\u640d\u50b7\uff0c\u4e26\u5c0e\u81f4\u7cd6\u5c3f\u75c5\u5927\u9f20\u7684 \u03b2 \u7d30\u80de\u9ad8\u723e\u57fa\u5340\u6301\u7e8c\u51fa\u73fe\u53ef\u80fd\u662f\u5206\u6ccc\u6027\u7684\u5c0f\u9846\u7c92\u3002\u93c8\u8132\u4f50\u83cc\u7d20\u5e38\u7528\u65bc\u8a98\u5c0e\u5be6\u9a57\u52d5\u7269\u7f79\u60a3\u7cd6\u5c3f\u75c5\u3002<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/biopioneer.com.tw\/wp-content\/uploads\/downloads\/2024\/11\/2-Streptozocin-CAS18883-66-4-APExBIO-%E8%B2%A8%E8%99%9FA4457.png\" \/><\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"http:\/\/biopioneer.com.tw\/wp-content\/uploads\/2023\/12\/citation-5_%E5%B7%A5%E4%BD%9C%E5%8D%80%E5%9F%9F-1.jpg\" width=\"297\" height=\"55\" \/><\/p>\n<ul id=\"artul\">\n<li><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37526952\" target=\"_blank\" rel=\"noopener\">1. Wenyu Dai, Rui Shu, et al. &#8220;Engineered Bio-Heterojunction Confers Extra- and Intracellular Bacterial Ferroptosis and Hunger-Triggered Cell Protection for Diabetic Wound Repair.&#8221; Adv Mater. 2024 Mar;36(9):e2305277. PMID: 37526952<\/a><\/li>\n<li><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33516884\" target=\"_blank\" rel=\"noopener\">2. Ying Deng, Wenyi Zhu, et al. &#8220;Exendin-4 promotes bone formation in diabetic states via HDAC1-Wnt\/\u03b2-catenin axis.&#8221; Biochem Biophys Res Commun. 2021 Mar 12;544:8-14. PMID: 33516884<\/a><\/li>\n<li><a>3. Ivana Stojanovic\u00b4, Katarina \u0160avikin, et al. &#8220;Pomegranate peel extract ameliorates autoimmunity in animal models of multiple sclerosis and type 1 diabetes.&#8221; Journal of Functional Foods 35 (2017) 522\u2013530.<\/a><\/li>\n<\/ul>\n<p><img decoding=\"async\" src=\"https:\/\/biopioneer.com.tw\/wp-content\/uploads\/downloads\/2024\/11\/3-Streptozocin-CAS18883-66-4-APExBIO-%E8%B2%A8%E8%99%9FA4457.jpg\" \/><\/p>\n<table>\n<tbody>\n<tr>\n<td>Physical Appearance<\/td>\n<td>A solid<\/td>\n<\/tr>\n<tr>\n<td>Storage<\/td>\n<td>Store at -20\u00b0C<\/td>\n<\/tr>\n<tr>\n<td>M.Wt<\/td>\n<td>265.22<\/td>\n<\/tr>\n<tr>\n<td>Cas No.<\/td>\n<td>18883-66-4<\/td>\n<\/tr>\n<tr>\n<td>Formula<\/td>\n<td>C<sub>8<\/sub>H<sub>15<\/sub>N<sub>3<\/sub>O<sub>7<\/sub><\/td>\n<\/tr>\n<tr>\n<td>Solubility<\/td>\n<td>\u226510.3 mg\/mL in DMSO; \u226526.5 mg\/mL in EtOH with gentle warming; \u226553.2 mg\/mL in H2O<\/td>\n<\/tr>\n<tr>\n<td>Chemical Name<\/td>\n<td>1-methyl-1-nitroso-3-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea<\/td>\n<\/tr>\n<tr>\n<td>SDF<\/td>\n<td><a href=\"https:\/\/www.apexbt.com\/downloader\/sdf\/A4457.sdf\">Download SDF<\/a><\/td>\n<\/tr>\n<tr>\n<td>Canonical SMILES<\/td>\n<td>O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(N(N=O)C)=O<\/td>\n<\/tr>\n<tr>\n<td>Shipping Condition<\/td>\n<td>Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice.<\/td>\n<\/tr>\n<tr>\n<td>General tips<\/td>\n<td>We do not recommend long-term storage for the solution, please use it up soon.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span style=\"font-size: 12pt;\"><a href=\"http:\/\/www.apexbt.com\/\">APExBIO\u53f0\u7063\u4ee3\u7406\u5546<\/a><\/span><\/h2>\n<p>APExBIO\u63d0\u4f9b\u512a\u8cea\u7684\u80dc\u80bd\u548c\u751f\u7269\u5206\u6790\u8a66\u5291\uff0c\u5ee3\u6cdb\u7522\u54c1\u7dda\u5982Protease\u3001Chromatin\/Epigenetics\u8868\u89c0\u907a\u50b3\u5b78\u3001MAPK Signal\u3001DNA Damege\/DNA repair\u3001\u7d30\u80de\u51cb\u4ea1\u3001\u816b\u7624\u751f\u7269\u5b78\u3001Stem cell\u7b49\u7814\u7a76\u9818\u57df\uff0c \u9084\u63d0\u4f9b\u5b9a\u5236\u7684\u670d\u52d9\uff0c\u5305\u62ec\u591a\u80bd\u5408\u6210\uff0c\u6297\u9ad4\u7684\u751f\u7522\u548c\u6aa2\u6e2c\u7684\u767c\u5c55\u3002\u7522\u54c1\u7ddaDNA\/RNA prep kit\u3001Drug Screening panel\u3001Bioactive peptides\u3001Growth factors\u3001Biotinylation Reagents\u3001tag peptides\u3001amino Acids\u3001Growth factors\u7b49\u3002APExBIO\u7522\u54c1\u8cea\u91cf\u90fd\u4f34\u96a8\u8457\u8b49\u66f8\u7684\u5206\u6790\uff0c\u9ad8\u6548\u6db2\u76f8\u8272\u8b5c\uff0c\u8cea\u8b5c\uff0c\u548cHMNR\u6578\u64da\u3002<\/p>\n<p><img decoding=\"async\" src=\"http:\/\/biopioneer.com.tw\/wp-content\/uploads\/2022\/12\/%E5%9E%8B%E9%8C%84%E4%B8%8B%E8%BC%89.gif\" alt=\"\u578b\u9304\u4e0b\u8f09\" \/><\/p>\n<table style=\"height: 613px;\" width=\"965\">\n<tbody>\n<tr>\n<td width=\"139\">\u54c1\u9805<\/td>\n<td width=\"139\">CAS#<\/td>\n<td width=\"138\">#\u8ca8\u865f<\/td>\n<td width=\"138\">\u61c9\u7528\u8a3b\u89e3<\/td>\n<\/tr>\n<tr>\n<td width=\"139\"><a href=\"http:\/\/biopioneer.com.tw\/?p=34272\">Z-VAD-FMK \u00a0<\/a><\/td>\n<td width=\"139\">CAS# 187389-52-2<\/td>\n<td width=\"138\">\u8ca8\u865f\u00a0A1902<\/td>\n<td width=\"138\">\n<p>Proteases<\/p>\n<p>ICE-like proteases<\/td>\n<\/tr>\n<tr>\n<td width=\"139\"><a href=\"http:\/\/biopioneer.com.tw\/?p=34285\">TAPI-1 \u00a0<\/a><\/td>\n<td width=\"139\">CAS#171235-71-5<\/td>\n<td width=\"138\">\u8ca8\u865f\u00a0B4686<\/td>\n<td width=\"138\">\n<p>Proteases<\/p>\n<p>TACE\/ADAM17 inhibitor Product Citation+3<\/td>\n<\/tr>\n<tr>\n<td width=\"139\"><a href=\"http:\/\/biopioneer.com.tw\/?p=34295\">Talabostat mesylate<\/a><\/td>\n<td width=\"139\">CAS# 150080-09-4<\/td>\n<td width=\"138\">\u8ca8\u865fB3941<\/td>\n<td width=\"138\">\n<p>Proteases<\/p>\n<p>DPP4 \u4e8c\u80bd\u57fa\u80bd\u9176\u7279\u7570\u6027\u6291\u5236\u5291<\/td>\n<\/tr>\n<tr>\n<td width=\"139\"><a href=\"http:\/\/biopioneer.com.tw\/?p=34301\">Z-IETD-FMK<\/a><\/td>\n<td width=\"139\">CAS# 210344-98-2<\/td>\n<td width=\"138\">\u8ca8\u865fB3232<\/td>\n<td width=\"138\">inhibitor of caspase 8<\/td>\n<\/tr>\n<tr>\n<td width=\"139\">Cisplatin<\/td>\n<td width=\"139\">CAS# 15663-27-1<\/td>\n<td width=\"138\">\u8ca8\u865fA8321<\/td>\n<td width=\"138\">\u9ad8\u6548\u3001\u5ee3\u8b5c\u7684\u5316\u7642\u85e5\u7269<\/td>\n<\/tr>\n<tr>\n<td width=\"139\"><a href=\"http:\/\/biopioneer.com.tw\/?p=34314\">17-DMAG (Alvespimycin) HCl<\/a><\/td>\n<td width=\"139\">CAS#467214-21-7<\/td>\n<td width=\"138\">\u00a0\u8ca8\u865fA2213<\/td>\n<td width=\"138\">Hsp90 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"139\"><a href=\"http:\/\/biopioneer.com.tw\/?p=34320\">CA-074 Me\u00a0<\/a><\/td>\n<td width=\"139\">CAS# 147859-80-1<\/td>\n<td width=\"138\">\u8ca8\u865fA8239<\/td>\n<td width=\"138\">Cathepsin B inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"139\"><a href=\"http:\/\/biopioneer.com.tw\/?p=34325\">VX-765<\/a><\/td>\n<td width=\"139\">CAS# 273404-37-8<\/td>\n<td width=\"138\">\u8ca8\u865fA8238<\/td>\n<td width=\"138\">Caspase-1 inhibitor<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<table width=\"1075\">\n<tbody>\n<tr>\n<td width=\"96\">A4324<\/td>\n<td width=\"375\">Pioglitazone HCl<\/td>\n<td width=\"158\">112529-15-4<\/td>\n<td width=\"79\">99.35%<\/td>\n<td width=\"367\">PPAR\u03b3 agonist<\/td>\n<\/tr>\n<tr>\n<td>A4325<\/td>\n<td>PF-2545920<\/td>\n<td>1292799-56-4<\/td>\n<td>99.90%<\/td>\n<td>PDE10A inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4326<\/td>\n<td>TAK-700 (Orteronel)<\/td>\n<td>426219-18-3<\/td>\n<td>99.44%<\/td>\n<td>Human 17,20-lyase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4327<\/td>\n<td>Tadalafil<\/td>\n<td>171596-29-5<\/td>\n<td>99.91%<\/td>\n<td>PDE5 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4328<\/td>\n<td>Rolipram<\/td>\n<td>61413-54-5<\/td>\n<td>98.19%<\/td>\n<td>PDE4-inhibitor and an anti-inflammatory agent<\/td>\n<\/tr>\n<tr>\n<td>A4329<\/td>\n<td>Cilomilast<\/td>\n<td>153259-65-5<\/td>\n<td>99.37%<\/td>\n<td>Potent PDE4 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4330<\/td>\n<td>Isotretinoin<\/td>\n<td>4759-48-2<\/td>\n<td>99.89%<\/td>\n<td>Dopamine \u03b2-hydroxylase activator<\/td>\n<\/tr>\n<tr>\n<td>A4331<\/td>\n<td>GSK256066<\/td>\n<td>801312-28-7<\/td>\n<td>98.39%<\/td>\n<td>PDE4-inhibitor,selective and highly potent<\/td>\n<\/tr>\n<tr>\n<td>A4332<\/td>\n<td>Nepicastat (SYN-117) HCl<\/td>\n<td>170151-24-3<\/td>\n<td>98.14%<\/td>\n<td>Dopamine-\u03b2-hydroxylase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4333<\/td>\n<td>CPI-613<\/td>\n<td>95809-78-2<\/td>\n<td>99.45%<\/td>\n<td>PDH\/\u03b1-KGDH inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4334<\/td>\n<td>Avanafil<\/td>\n<td>330784-47-9<\/td>\n<td>99.07%<\/td>\n<td>PDE5 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4335<\/td>\n<td>Mildronate<\/td>\n<td>76144-81-5<\/td>\n<td>98.33%<\/td>\n<td>GBB hydroxylase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4336<\/td>\n<td>Mycophenolate Mofetil<\/td>\n<td>128794-94-5<\/td>\n<td>99.67%<\/td>\n<td>IMPDH inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4337<\/td>\n<td>Cilostazol<\/td>\n<td>73963-72-1<\/td>\n<td>99.94%<\/td>\n<td>PDE3 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4338<\/td>\n<td>Rivaroxaban<\/td>\n<td>366789-02-8<\/td>\n<td>99.91%<\/td>\n<td>Factor Xa inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4339<\/td>\n<td>AGI-5198<\/td>\n<td>1355326-35-0<\/td>\n<td>97.43%<\/td>\n<td>IDH1 inhibitor against R132 mutant,selective and cell-permeable<\/td>\n<\/tr>\n<tr>\n<td>A4340<\/td>\n<td>Pimobendan<\/td>\n<td>74150-27-9<\/td>\n<td>99.25%<\/td>\n<td>Selective PDE3 inhibitor.Ca2+ channel sensitizer<\/td>\n<\/tr>\n<tr>\n<td>A4341<\/td>\n<td>Apixaban<\/td>\n<td>503612-47-3<\/td>\n<td>99.87%<\/td>\n<td>Factor Xa inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4342<\/td>\n<td>Gimeracil<\/td>\n<td>103766-25-2<\/td>\n<td>99.82%<\/td>\n<td>Dihydropyrimidine dehydrogenase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4343<\/td>\n<td>Dyphylline<\/td>\n<td>479-18-5<\/td>\n<td>99.84%<\/td>\n<td>Pan-PDE inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4344<\/td>\n<td>Ozagrel<\/td>\n<td>82571-53-7<\/td>\n<td>99.84%<\/td>\n<td>Thromboxane A2 synthetase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4345<\/td>\n<td>MK-8245<\/td>\n<td>1030612-90-8<\/td>\n<td>99.76%<\/td>\n<td>SCD inhibitor,potent and liver-selective<\/td>\n<\/tr>\n<tr>\n<td>A4346<\/td>\n<td>Aminophylline<\/td>\n<td>317-34-0<\/td>\n<td>99.05%<\/td>\n<td>Pan-PDE inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4347<\/td>\n<td>Methotrexate<\/td>\n<td>59-05-2<\/td>\n<td>99.14%<\/td>\n<td>Folate antagonist,inhibits DFHR<\/td>\n<\/tr>\n<tr>\n<td>A4348<\/td>\n<td>Trilostane<\/td>\n<td>13647-35-3<\/td>\n<td>99.58%<\/td>\n<td>3\u03b2-HSD inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4349<\/td>\n<td>S- (+)-Rolipram<\/td>\n<td>85416-73-5<\/td>\n<td>99.93%<\/td>\n<td>CAMP-specific PDE4 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4350<\/td>\n<td>Pralatrexate<\/td>\n<td>146464-95-1<\/td>\n<td>98.47%<\/td>\n<td>Antifolate,a folate analog<\/td>\n<\/tr>\n<tr>\n<td>A4351<\/td>\n<td>PluriSIn #1 (NSC 14613)<\/td>\n<td>91396-88-2<\/td>\n<td>99.32%<\/td>\n<td>SCD1 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4352<\/td>\n<td>Anagrelide HCl<\/td>\n<td>58579-51-4<\/td>\n<td>99.62%<\/td>\n<td>Thrombocytopenic agent<\/td>\n<\/tr>\n<tr>\n<td>A4353<\/td>\n<td>Pyrimethamine<\/td>\n<td>58-14-0<\/td>\n<td>99.65%<\/td>\n<td>DHFR inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4354<\/td>\n<td>UK 383367<\/td>\n<td>348622-88-8<\/td>\n<td>98.00%<\/td>\n<td>BMP-1\/PCP inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4355<\/td>\n<td>Tosedostat (CHR2797)<\/td>\n<td>238750-77-1<\/td>\n<td>98.96%<\/td>\n<td>Aminopeptidase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4356<\/td>\n<td>Varespladib (LY315920)<\/td>\n<td>172732-68-2<\/td>\n<td>98.00%<\/td>\n<td>HnsPLA inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4357<\/td>\n<td>Dorzolamide HCl<\/td>\n<td>130693-82-2<\/td>\n<td>99.87%<\/td>\n<td>Carbonic anhydrase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4358<\/td>\n<td>U-104<\/td>\n<td>178606-66-1<\/td>\n<td>99.82%<\/td>\n<td>CAIX inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4359<\/td>\n<td>Brinzolamide<\/td>\n<td>138890-62-7<\/td>\n<td>99.88%<\/td>\n<td>CA II inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4360<\/td>\n<td>Topiramate<\/td>\n<td>97240-79-4<\/td>\n<td>100.00%<\/td>\n<td>GluR5 receptor antagonist,anticonvulsant<\/td>\n<\/tr>\n<tr>\n<td>A4361<\/td>\n<td>JNJ-1661010<\/td>\n<td>681136-29-8<\/td>\n<td>98.00%<\/td>\n<td>FAAH inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4362<\/td>\n<td>Tioxolone<\/td>\n<td>4991-65-5<\/td>\n<td>98.67%<\/td>\n<td>CAI inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4363<\/td>\n<td>Fluvastatin Sodium<\/td>\n<td>93957-55-2<\/td>\n<td>98.84%<\/td>\n<td>HMG-CoA reductase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4364<\/td>\n<td>Methazolamide<\/td>\n<td>554-57-4<\/td>\n<td>99.79%<\/td>\n<td>Carbonic anhydrase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4365<\/td>\n<td>Lovastatin<\/td>\n<td>75330-75-5<\/td>\n<td>98.58%<\/td>\n<td>HMG-CoA reductase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4366<\/td>\n<td>Rasagiline Mesylate<\/td>\n<td>161735-79-1<\/td>\n<td>99.23%<\/td>\n<td>Irreversible MAO-B inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4367<\/td>\n<td>Atorvastatin Calcium<\/td>\n<td>134523-03-8<\/td>\n<td>99.76%<\/td>\n<td>HMG-CoA reductase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4368<\/td>\n<td>Safinamide Mesylate<\/td>\n<td>202825-46-5<\/td>\n<td>98.60%<\/td>\n<td>MAO-B inhibitor,potent,selective and reversible<\/td>\n<\/tr>\n<tr>\n<td>A4369<\/td>\n<td>Pravastatin sodium<\/td>\n<td>81131-70-6<\/td>\n<td>98.00%<\/td>\n<td>HMG-CoA reductase inhibitor,highly selective and competitive<\/td>\n<\/tr>\n<tr>\n<td>A4370<\/td>\n<td>Moclobemide (Ro 111163)<\/td>\n<td>71320-77-9<\/td>\n<td>99.85%<\/td>\n<td>Reversible inhibitor of MAO-A<\/td>\n<\/tr>\n<tr>\n<td>A4371<\/td>\n<td>Ferrostatin-1 (Fer-1)<\/td>\n<td>347174-05-4<\/td>\n<td>99.75%<\/td>\n<td>Ferroptosis inhibitor, erastin-induced<\/td>\n<\/tr>\n<tr>\n<td>A4372<\/td>\n<td>URB597<\/td>\n<td>546141-08-6<\/td>\n<td>99.58%<\/td>\n<td>FAAH inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4373<\/td>\n<td>NLG919<\/td>\n<td>1402836-58-1<\/td>\n<td>99.79%<\/td>\n<td>Potent IDO pathway inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4374<\/td>\n<td>PF-3845<\/td>\n<td>1196109-52-0<\/td>\n<td>98.00%<\/td>\n<td>FAAH ihibitor,highly potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4375<\/td>\n<td>Anacetrapib (MK-0859)<\/td>\n<td>875446-37-0<\/td>\n<td>99.76%<\/td>\n<td>RhCETP\/mutant CETP(C13S) inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4376<\/td>\n<td>Dalcetrapib (JTT-705, RO4607381)<\/td>\n<td>211513-37-0<\/td>\n<td>98.00%<\/td>\n<td>rhCETP inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4377<\/td>\n<td>Evacetrapib (LY2484595)<\/td>\n<td>1186486-62-3<\/td>\n<td>98.83%<\/td>\n<td>CETP inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4378<\/td>\n<td>Torcetrapib<\/td>\n<td>262352-17-0<\/td>\n<td>98.00%<\/td>\n<td>CETP inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4379<\/td>\n<td>Lonafarnib<\/td>\n<td>193275-84-2<\/td>\n<td>98.00%<\/td>\n<td>Ftase inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4381<\/td>\n<td>FK866 (APO866)<\/td>\n<td>658084-64-1<\/td>\n<td>99.58%<\/td>\n<td>NAMPT inhibitor, non-competitive, highly specific<\/td>\n<\/tr>\n<tr>\n<td>A4382<\/td>\n<td>A922500<\/td>\n<td>959122-11-3<\/td>\n<td>97.62%<\/td>\n<td>DGAT-1 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4383<\/td>\n<td>Tolcapone<\/td>\n<td>134308-13-7<\/td>\n<td>99.42%<\/td>\n<td>COMT inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4384<\/td>\n<td>PF-04620110<\/td>\n<td>1109276-89-2<\/td>\n<td>98.00%<\/td>\n<td>DGAT-1 inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4385<\/td>\n<td>Ganetespib (STA-9090)<\/td>\n<td>888216-25-9<\/td>\n<td>99.03%<\/td>\n<td>Hsp90 inhibitor,non-geldanamycin<\/td>\n<\/tr>\n<tr>\n<td>A4386<\/td>\n<td>Elesclomol (STA-4783)<\/td>\n<td>488832-69-5<\/td>\n<td>98.00%<\/td>\n<td>Oxidative stress\/apoptosis inducer,potent and novel<\/td>\n<\/tr>\n<tr>\n<td>A4387<\/td>\n<td>VER 155008<\/td>\n<td>1134156-31-2<\/td>\n<td>99.72%<\/td>\n<td>HSP 70 inhibitor,adenosine-derived<\/td>\n<\/tr>\n<tr>\n<td>A4388<\/td>\n<td>XL-888<\/td>\n<td>1149705-71-4<\/td>\n<td>98.00%<\/td>\n<td>Hsp90 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4390<\/td>\n<td>Pemetrexed<\/td>\n<td>150399-23-8<\/td>\n<td>99.88%<\/td>\n<td>TS, DHFR,GARFT and AICARFT inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4393<\/td>\n<td>Paclitaxel (Taxol)<\/td>\n<td>33069-62-4<\/td>\n<td>99.71%<\/td>\n<td>Antineoplastic agent<\/td>\n<\/tr>\n<tr>\n<td>A4394<\/td>\n<td>Docetaxel<\/td>\n<td>114977-28-5<\/td>\n<td>98.56%<\/td>\n<td>Microtubulin disassembly inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4395<\/td>\n<td>10-DAB (10-Deacetylbaccatin)<\/td>\n<td>32981-86-5<\/td>\n<td>98.26%<\/td>\n<td>Precursor of antitumor compound Palitaxel and Docetaxel<\/td>\n<\/tr>\n<tr>\n<td>A4400<\/td>\n<td>BMS 299897<\/td>\n<td>290315-45-6<\/td>\n<td>98.00%<\/td>\n<td>\u03b3&#8211;secretase inhibitor, potent and orally active<\/td>\n<\/tr>\n<tr>\n<td>A4401<\/td>\n<td>Compound W<\/td>\n<td>173550-33-9<\/td>\n<td>98.00%<\/td>\n<td>\u03b3-secretase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4402<\/td>\n<td>Flurizan<\/td>\n<td>51543-40-9<\/td>\n<td>99.76%<\/td>\n<td>NSAID,inhibits \u03b3-secretase activity<\/td>\n<\/tr>\n<tr>\n<td>A4403<\/td>\n<td>JLK 6<\/td>\n<td>62252-26-0<\/td>\n<td>98.00%<\/td>\n<td>\u03b3-secretase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4404<\/td>\n<td>L-685,458<\/td>\n<td>292632-98-5<\/td>\n<td>99.25%<\/td>\n<td>\u03b3-secretase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4405<\/td>\n<td>MRK 560<\/td>\n<td>677772-84-8<\/td>\n<td>98.00%<\/td>\n<td>\u03b3-secretase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4406<\/td>\n<td>Begacestat<\/td>\n<td>769169-27-9<\/td>\n<td>98.00%<\/td>\n<td>\u03b3-secretase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4407<\/td>\n<td>Fumagillin<\/td>\n<td>23110-15-8<\/td>\n<td>98.00%<\/td>\n<td>Antibiotic and antiangiogenic agent<\/td>\n<\/tr>\n<tr>\n<td>A4408<\/td>\n<td>SC 57461A<\/td>\n<td>423169-68-0<\/td>\n<td>98.00%<\/td>\n<td>LTA4 hydrolase inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4409<\/td>\n<td>Spinorphin<\/td>\n<td>137201-62-8<\/td>\n<td>98.00%<\/td>\n<td>P2X3 receptors against<\/td>\n<\/tr>\n<tr>\n<td>A4410<\/td>\n<td>Acetyl-Calpastatin (184-210) (human)<\/td>\n<td>123714-50-1<\/td>\n<td>98.00%<\/td>\n<td>Calpain I\/II inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4411<\/td>\n<td>Calpeptin<\/td>\n<td>117591-20-5<\/td>\n<td>98.00%<\/td>\n<td>Ca2+-dependent protease,calpain inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4412<\/td>\n<td>MDL 28170<\/td>\n<td>88191-84-8<\/td>\n<td>98.00%<\/td>\n<td>Calpain and cathepsin B inhibitor, selective<\/td>\n<\/tr>\n<tr>\n<td>A4413<\/td>\n<td>PD 150606<\/td>\n<td>179528-45-1<\/td>\n<td>98.00%<\/td>\n<td>Non-peptide calpain inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4414<\/td>\n<td>PMPA (NAALADase inhibitor)<\/td>\n<td>173039-10-6<\/td>\n<td>98.00%<\/td>\n<td>Glutamate carboxypeptidase 2 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4415<\/td>\n<td>ZJ 43<\/td>\n<td>723331-20-2<\/td>\n<td>98.00%<\/td>\n<td>GCP II and III\/NAAG peptidase\/NAALADase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4416<\/td>\n<td>AZ 10417808<\/td>\n<td>331645-84-2<\/td>\n<td>98.00%<\/td>\n<td>Caspase-3 inhibitor,selective non-peptide<\/td>\n<\/tr>\n<tr>\n<td>A4417<\/td>\n<td>Ivachtin<\/td>\n<td>745046-84-8<\/td>\n<td>98.00%<\/td>\n<td>Caspase-3 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4418<\/td>\n<td>Ac-IEPD-AFC<\/td>\n<td>1135417-31-0<\/td>\n<td>96.06%<\/td>\n<td>Recognition motif for serine protease granzyme B<\/td>\n<\/tr>\n<tr>\n<td>A4419<\/td>\n<td>Ac-LEHD-AFC<\/td>\n<td>210345-03-2<\/td>\n<td>\u226595.00%<\/td>\n<td>Fluorogenic caspase substrate<\/td>\n<\/tr>\n<tr>\n<td>A4420<\/td>\n<td>PETCM<\/td>\n<td>10129-56-3<\/td>\n<td>98.00%<\/td>\n<td>Caspase-3 activator<\/td>\n<\/tr>\n<tr>\n<td>A4422<\/td>\n<td>L 006235<\/td>\n<td>294623-49-7<\/td>\n<td>98.00%<\/td>\n<td>Cathepsin K inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4424<\/td>\n<td>SID 26681509<\/td>\n<td>958772-66-2<\/td>\n<td>98.00%<\/td>\n<td>Human cathepsin L inhibitor,potent and reversible<\/td>\n<\/tr>\n<tr>\n<td>A4425<\/td>\n<td>DPPI 1c hydrochloride<\/td>\n<td>866396-34-1<\/td>\n<td>98.00%<\/td>\n<td>DPP-IV Inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4426<\/td>\n<td>K 579<\/td>\n<td>440100-64-1<\/td>\n<td>98.00%<\/td>\n<td>Dipeptidyl peptidase IV inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4427<\/td>\n<td>NVP DPP 728 dihydrochloride<\/td>\n<td>247016-69-9<\/td>\n<td>96.76%<\/td>\n<td>DPP-IV inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4428<\/td>\n<td>PK 44 phosphate<\/td>\n<td>1017682-65-3<\/td>\n<td>98.00%<\/td>\n<td>DPP-IV inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4429<\/td>\n<td>Vialinin A<\/td>\n<td>858134-23-3<\/td>\n<td>98.00%<\/td>\n<td>USP\/isopeptidase T (IsoT)\/UCH-L1 DUB inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4430<\/td>\n<td>Sivelestat sodium salt<\/td>\n<td>150374-95-1<\/td>\n<td>98.00%<\/td>\n<td>Leukocyte elastase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4431<\/td>\n<td>SSR 69071<\/td>\n<td>344930-95-6<\/td>\n<td>\u226595.00%<\/td>\n<td>HLE inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4432<\/td>\n<td>ARP 100<\/td>\n<td>704888-90-4<\/td>\n<td>98.00%<\/td>\n<td>Selective MMP-2 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4433<\/td>\n<td>ARP 101<\/td>\n<td>849773-63-3<\/td>\n<td>98.00%<\/td>\n<td>MMP inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4434<\/td>\n<td>CL 82198 hydrochloride<\/td>\n<td>307002-71-7<\/td>\n<td>98.00%<\/td>\n<td>Selective MMP-13 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4435<\/td>\n<td>CP 471474<\/td>\n<td>210755-45-6<\/td>\n<td>98.00%<\/td>\n<td>Broad spectrum MMP inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4436<\/td>\n<td>GI 254023X<\/td>\n<td>260264-93-5<\/td>\n<td>98.00%<\/td>\n<td>Selective inhibitor of ADAM10 metalloprotease<\/td>\n<\/tr>\n<tr>\n<td>A4437<\/td>\n<td>ONO 4817<\/td>\n<td>223472-31-9<\/td>\n<td>98.00%<\/td>\n<td>MMP inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4438<\/td>\n<td>PD 166793<\/td>\n<td>199850-67-4<\/td>\n<td>98.00%<\/td>\n<td>MMP inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4440<\/td>\n<td>UK 356618<\/td>\n<td>230961-08-7<\/td>\n<td>98.00%<\/td>\n<td>MMP-3 inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4441<\/td>\n<td>UK 370106<\/td>\n<td>230961-21-4<\/td>\n<td>98.00%<\/td>\n<td>MMP-3\/MMP-12 Inhiibitor,highly selective<\/td>\n<\/tr>\n<tr>\n<td>A4442<\/td>\n<td>WAY 170523<\/td>\n<td>307002-73-9<\/td>\n<td>98.00%<\/td>\n<td>MMP-13 inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td>A4443<\/td>\n<td>Gliotoxin<\/td>\n<td>67-99-2<\/td>\n<td>98.00%<\/td>\n<td>20S proteasome inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4444<\/td>\n<td>BC 11 hydrobromide<\/td>\n<td>443776-49-6<\/td>\n<td>98.00%<\/td>\n<td>Selective urokinase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4445<\/td>\n<td>4-Chlorophenylguanidine hydrochloride<\/td>\n<td>14279-91-5<\/td>\n<td>98.00%<\/td>\n<td>Urokinase inhibitor, potent and specific<\/td>\n<\/tr>\n<tr>\n<td>A4446<\/td>\n<td>R18<\/td>\n<td>211364-78-2<\/td>\n<td>98.00%<\/td>\n<td>14.3.3 proteins Antagonist<\/td>\n<\/tr>\n<tr>\n<td>A4447<\/td>\n<td>2,3-DCPE hydrochloride<\/td>\n<td>418788-90-6<\/td>\n<td>98.00%<\/td>\n<td>Bcl-XL protein expression downregulator<\/td>\n<\/tr>\n<tr>\n<td>A4448<\/td>\n<td>Actinomycin D<\/td>\n<td>50-76-0<\/td>\n<td>98.00%<\/td>\n<td>RNA polymerase inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4449<\/td>\n<td>C 75<\/td>\n<td>191282-48-1<\/td>\n<td>98.00%<\/td>\n<td>Fatty acid synthase (FAS) inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4450<\/td>\n<td>CHM 1<\/td>\n<td>154554-41-3<\/td>\n<td>98.00%<\/td>\n<td>Tubulin polymerization inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4451<\/td>\n<td>Deguelin<\/td>\n<td>522-17-8<\/td>\n<td>98.00%<\/td>\n<td>Anticancer and antiviral agent<\/td>\n<\/tr>\n<tr>\n<td>A4452<\/td>\n<td>Mitomycin C<\/td>\n<td>50-07-7<\/td>\n<td>98.00%<\/td>\n<td>Inhibits DNA synthesis,antibiotic and antitumor agent<\/td>\n<\/tr>\n<tr>\n<td>A4453<\/td>\n<td>NSC 687852 (b-AP15)<\/td>\n<td>1009817-63-3<\/td>\n<td>98.15%<\/td>\n<td>19S regulatory particle Inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4454<\/td>\n<td>Oncrasin 1<\/td>\n<td>75629-57-1<\/td>\n<td>98.00%<\/td>\n<td>Proapoptotic agent<\/td>\n<\/tr>\n<tr>\n<td>A4455<\/td>\n<td>Piperlongumine<\/td>\n<td>20069-09-4<\/td>\n<td>98.00%<\/td>\n<td>Inducer of cell-death<\/td>\n<\/tr>\n<tr>\n<td>A4456<\/td>\n<td>Plumbagin<\/td>\n<td>481-42-5<\/td>\n<td>98.00%<\/td>\n<td>Anticancer agent<\/td>\n<\/tr>\n<tr>\n<td>A4457<\/td>\n<td>Streptozocin<\/td>\n<td>18883-66-4<\/td>\n<td>98.00%<\/td>\n<td>Antibiotic and antitumor agent<\/td>\n<\/tr>\n<tr>\n<td>A4458<\/td>\n<td>ARRY 520 trifluoroacetate<\/td>\n<td>885060-09-3<\/td>\n<td>98.00%<\/td>\n<td>KSP inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4459<\/td>\n<td>Bax channel blocker<\/td>\n<td>335165-68-9<\/td>\n<td>98.00%<\/td>\n<td>Inhibitor of Bax-mediated mitochondrial cytochrome c release<\/td>\n<\/tr>\n<tr>\n<td>A4460<\/td>\n<td>Bax inhibitor peptide P5<\/td>\n<td>579492-83-4<\/td>\n<td>99.59%<\/td>\n<td>Bax inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4461<\/td>\n<td>Bax inhibitor peptide V5<\/td>\n<td>579492-81-2<\/td>\n<td>99.19%<\/td>\n<td>Bax inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4463<\/td>\n<td>BIM, Biotinylated<\/td>\n<td><\/td>\n<td>99.04%<\/td>\n<td>Bim peptide fragment with a biotin moiety attached<\/td>\n<\/tr>\n<tr>\n<td>A4465<\/td>\n<td>MIM1<\/td>\n<td>509102-00-5<\/td>\n<td>98.69%<\/td>\n<td>Mcl-1 Inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4466<\/td>\n<td>Muristerone A<\/td>\n<td>38778-30-2<\/td>\n<td>\u226595.00%<\/td>\n<td>TRAIL- and hFasL-induced apoptosis inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4467<\/td>\n<td>SU 9516<\/td>\n<td>377090-84-1<\/td>\n<td>98.00%<\/td>\n<td>Cdk2 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4468<\/td>\n<td>Cesium chloride<\/td>\n<td>7647-17-8<\/td>\n<td>98.00%<\/td>\n<td>Potassium channel blocker<\/td>\n<\/tr>\n<tr>\n<td>A4469<\/td>\n<td>DAPK Substrate Peptide<\/td>\n<td>386769-53-5<\/td>\n<td>98.00%<\/td>\n<td>Synthetic peptide substrate for DAPK<\/td>\n<\/tr>\n<tr>\n<td>A4471<\/td>\n<td>GRI 977143<\/td>\n<td>325850-81-5<\/td>\n<td>98.00%<\/td>\n<td>LPA2 receptor non-lipid agonist<\/td>\n<\/tr>\n<tr>\n<td>A4472<\/td>\n<td>Mdivi 1<\/td>\n<td>338967-87-6<\/td>\n<td>99.52%<\/td>\n<td>Selective DRP1\/Dnm1 inhibitor, cell-permeable<\/td>\n<\/tr>\n<tr>\n<td>A4473<\/td>\n<td>Melphalan<\/td>\n<td>148-82-3<\/td>\n<td>98.00%<\/td>\n<td>DNA alkylating agent<\/td>\n<\/tr>\n<tr>\n<td>A4474<\/td>\n<td>NQDI 1<\/td>\n<td>175026-96-7<\/td>\n<td>98.00%<\/td>\n<td>ASK1, MAP3K5 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4475<\/td>\n<td>TLQP 21<\/td>\n<td>869988-94-3<\/td>\n<td>98.00%<\/td>\n<td>VGF-derived peptide<\/td>\n<\/tr>\n<tr>\n<td>A4476<\/td>\n<td>CP 31398 dihydrochloride<\/td>\n<td>1217195-61-3<\/td>\n<td>98.00%<\/td>\n<td>p53 stabilizer<\/td>\n<\/tr>\n<tr>\n<td>A4477<\/td>\n<td>Cyclic Pifithrin-\u03b1 hydrobromide<\/td>\n<td>511296-88-1<\/td>\n<td>99.34%<\/td>\n<td>P53 inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4478<\/td>\n<td>HLI 373<\/td>\n<td>502137-98-6<\/td>\n<td>98.00%<\/td>\n<td>Hdm2 ubiquitin ligase (E3) inhibitor<\/td>\n<\/tr>\n<tr>\n<td>A4479<\/td>\n<td>MIRA-1<\/td>\n<td>72835-26-8<\/td>\n<td>98.00%<\/td>\n<td>Restorer of wild-type p53 conformation\/cellular function<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u6297\u751f\u7d20\u548c\u6297\u816b\u7624\u5291\u7cfb\u5217\u5546\u54c1-&gt;&gt;Streptozocin APExBIO Technology LL [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":47343,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[5368],"tags":[6799],"_links":{"self":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/50431"}],"collection":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=50431"}],"version-history":[{"count":7,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/50431\/revisions"}],"predecessor-version":[{"id":53847,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/50431\/revisions\/53847"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/media\/47343"}],"wp:attachment":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=50431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=50431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=50431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}